Cas:17391-18-3 Corynoxine B manufacturer & supplier

We serve Chemical Name:Corynoxine B CAS:17391-18-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Corynoxine B

Chemical Name:Corynoxine B
CAS.NO:17391-18-3
Synonyms:Spiro[3H-indole-3,1′(5’H)-indolizine]-7′-acetic acid, 6′-ethyl-1,2,2′,3′,6′,7′,8′,8’a-octahydro-α-(methoxymethylene)-2-oxo-, methyl ester, (αE,3R,6’S,7’S,8’aS)-;Corynoxine B;Methyl (7β,16E)-16-(methoxymethylene)-2-oxocorynoxan-17-oate
Molecular Formula:C22H28N2O4
Molecular Weight:384.469
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:560.8±50.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.596
PSA:67.87000
Exact Mass:384.204895
LogP:3.31

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Spiro[3H-indole-3,1′(5’H)-indolizine]-7′-acetic acid, 6′-ethyl-1,2,2′,3′,6′,7′,8′,8’a-octahydro-α-(methoxymethylene)-2-oxo-, methyl ester, (αE,3R,6’S,7’S,8’aS)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl (7β,16E)-16-(methoxymethylene)-2-oxocorynoxan-17-oate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Spiro[3H-indole-3,1′(5’H)-indolizine]-7′-acetic acid, 6′-ethyl-1,2,2′,3′,6′,7′,8′,8’a-octahydro-α-(methoxymethylene)-2-oxo-, methyl ester, (αE,3R,6’S,7’S,8’aS)- Use and application,Corynoxine B technical grade,usp/ep/jp grade.


Related News: Except current data is insufficient to determine its benefit in patients who are negative for anti-AChR antibodies. 5-(hydroxymethyl)-2-methoxy-N-(4-(trifluoromethyl)benzyl)benzamide manufacturers Today’s announcement is strongly aligned to IDA Ireland’s Regional pillar and its continued commitment to winning jobs and investment in regional locations. I wish Charles River every success with this expansion.” (6aR,10aR)-(-)-3-(5-tert-butyldimethylsilyloxypentyl)-6a,7,10,10-tetrahydro-1-methoxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9(8H)-one suppliers in addition to standard therapy. The trial did not meet its primary endpoint based on the SLE Responder Index 4 (SRI4) composite measure. 1-p-Fluorphenyl-hept-6-in-1-on vendor & factory.